title: CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation.
abstract: NK cell differentiation mainly occurs in the bone marrow (BM) where a critical role in the regulation of developing lymphocyte distribution is played by members of the chemokine receptor family. In mouse, the chemokine receptor CX3CR1 identifies a late stage of NK cell development characterized by decreased effector functions and expression of the inhibitory receptor KLRG1. The role of CX3CR1 in the regulation of differentiation and positioning of NK cell subsets in the BM is not known. In this study, we found that CX3CR1 deficiency leads to accumulation of KLRG1(+) NK cells in BM during steady-state conditions. The NK cell subset that expresses the receptor in wild-type mice was expanded in several tissues of CX3CR1-deficient mice, and NK cell degranulation in response to sensitive target cell stimulation was enhanced, suggesting a regulatory role of CX3CR1 in NK cell positioning and differentiation in BM. Indeed, the observed NK cell expansion was not due to altered turnover rate, whereas it was associated with preferential accumulation in the BM parenchyma. In addition, a role of CX3CR1 in NK cell trafficking from BM and spleen was evidenced also during inflammation, as CX3CR1-deficient NK cells were more prompt to exit the BM and did not decrease in spleen in response to polyinosinic-polycytidylic acid-promoted hepatitis. Overall, our results evidenced a relevant role of CX3CR1 in the regulation of NK cell subset exit from BM during homeostasis, and suggest that defect in the CX3CR1/CX3CL1 axis alters NK cell trafficking and functional response during inflammatory conditions.
authors.affiliation: Dipartimento di Medicina Molecolare Istituto Pasteur-Fondazione Cenci Bolognetti, Università di Roma "La Sapienza," 00161 Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Ponzetta
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Sciumè
authors.forename: Giorgia
authors.initials: G
authors.lastname: Benigni
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Antonangeli
authors.forename: Stefania
authors.initials: S
authors.lastname: Morrone
authors.forename: Angela
authors.initials: A
authors.lastname: Santoni
authors.forename: Giovanni
authors.initials: G
authors.lastname: Bernardini
mesh_terms: D000818:Animals; D001775:Blood Circulation; D001854:Bone Marrow Cells / Q000276:immunology; D000073883:CX3C Chemokine Receptor 1; D015550:Cell Degranulation / Q000235:genetics; D002454:Cell Differentiation / Q000235:genetics; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation; D003602:Cytotoxicity, Immunologic / Q000235:genetics; D005260:Female; D006505:Hepatitis / Q000276:immunology*; D006706:Homeostasis / Q000235:genetics; D007694:Killer Cells, Natural / Q000276:immunology*; D037181:Lectins, C-Type; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011070:Poly I-C / Q000276:immunology; D019707:Receptors, Chemokine / Q000235:genetics / Q000378:metabolism*; D011971:Receptors, Immunologic / Q000378:metabolism
chemical_list: D000073883:CX3C Chemokine Receptor 1; C471885:Cx3cr1 protein, mouse; C451496:Klrg1 protein, mouse; D037181:Lectins, C-Type; D019707:Receptors, Chemokine; D011971:Receptors, Immunologic; D011070:Poly I-C